iCAD provides AI-powered breast and colon health solutions for early cancer detection and risk assessment.
What is iCAD?
iCAD is a globally leading provider of clinically validated AI-driven solutions for breast health, dedicated to creating a world where cancer has no place to hide. Their ProFound breast health suite includes solutions for cancer detection, density assessment, and risk evaluation, all of which are supported by scientific and clinical evidence. iCAD’s AI-powered solutions help radiologists detect more aggressive cancers at an earlier stage, reduce interpretation time, and provide consistent density measurements – thereby improving patient outcomes and saving lives. They also offer solutions for colon health and collaborate with various partners within the industry.
How to use iCAD?
To utilize iCAD’s solutions, healthcare providers can integrate the ProFound Breast Health Suite into their existing workflows. Patients can access information regarding AI-driven mammography examinations and available resources on the iCAD website. Demos are also available upon request to demonstrate how these solutions can be effectively applied in practice.
The core features of iCAD
AI-driven cancer detection
Density assessment
Risk assessment
Seamless integration of work processes
Flexible deployment options